Karen Lam (researcher) explained

Fields:Medicine
Workplaces:University of Hong Kong
Known For:Diabetes and obesity research

Karen Lam Siu-ling is known for her research on diabetes and obesity. She is the Rosie T.T. Young Professor in Endocrinology and Metabolism at the University of Hong Kong.

Education and career

Lam graduated from the Diocesan Girls' School in Hong Kong in 1969[1] and graduated from the University of Hong Kong medical school in 1976.[2] She received additional training at Queen Mary Hospital in Hong Kong, St Bartholomew's Hospital in London, and Tufts Medical Center in the United States.[3] Lam was the first president of Diabetes Hong Kong, and has been the honorary president since 2014.[4] She was the first women to lead the department of medicine at Hong Kong University, a position she holds as of 2022. She was named the Rosie T.T. Young Professor in Endocrinology and Metabolism in 2005, and she is director of clinical trials at the University of Hong Kong.[5]

Research

Lam's research centers on diabetes, obesity, and cardiovascular diseases, with a particular focus on hormones in fat cells. A portion of her research examines adipocyte fatty acid binding protein from fat cells, where she has provided details on where it is secreted, and its impacts on diabetes and other diseases.[6] She has examined adiponectin and cancer in diabetes patients,[7] and detailed therapeutic compounds in traditional Chinese medications.[8] Her research has defined connections between obesity and cardiovascular disease[9] [10] and metabolic syndrome.[11] Lam worked to establish diabetes education in Hong Kong through specialized training of nurses and patients, both projects established with private funding.[12] In 1994 she established Hong Kong's first diabetes center at Queen Mary Hospital,[13] an idea that was later spread to other hospitals in Hong Kong.

Selected publications

Awards and honors

In 2008, Lam was honored as by the Hong Kong Women Professional and Entrepreneurs' Association for her work on hormones that help fight diabetes.[14]

Notes and References

  1. Web site: Karen Lam . 2022-02-19 . Diocesan Old Girls' Association.
  2. Web site: Established Endowed Professorships . 2022-02-19 . The University of Hong Kong Development & Alumni Affairs Office.
  3. Web site: Karen Lam, MBBS, MD. 2022-02-19. www.endocrine.org. en.
  4. Web site: Speakers at 2017 Diabetes Malaysia conference. February 19, 2022. Diabetes Malaysia.
  5. Web site: Wong . Billy SK . 2017-12-17 . Surge in clinical trials helps city speed new treatments to market . 2022-03-27 . South China Morning Post . en.
  6. News: Cremer . John . 2009-03-14 . Women of Distinction: Hard work fuels quest for success . en . 2 . South China Morning Post . subscription . 2022-03-27 . . ProQuest.
  7. Lee. Chi Ho. Lui. David T W. Cheung. Chloe Y Y. Fong. Carol H Y. Yuen. Michele M A. Chow. Wing Sun. Woo. Yu Cho. Xu. Aimin. Lam. Karen S L. 2020-04-01. Higher Circulating Adiponectin Concentrations Predict Incident Cancer in Type 2 Diabetes - The Adiponectin Paradox. The Journal of Clinical Endocrinology and Metabolism. 105. 4. e1387–e1396. 10.1210/clinem/dgaa075. 1945-7197. 32072163. 211191424. free.
  8. Xu. A.. Wang. H.. Hoo. R. L.. Sweeney. G.. Vanhoutte. P. M.. Wang. Y.. Wu. D.. Chu. W.. Qin. G.. Lam. K. S.. 2009. Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice.. Endocrinology. 150. 2. 625–633. 10.1210/en.2008-0999. 0013-7227. 18927219. 2732290.
  9. Chow. Wing Sun. Tso. Annette Wai Kwan. Xu. Aimin. Yuen. Michele Mae Ann. Fong. Carol Ho Yi. Lam. Tai Hing. Lo. Su Vui. Tse. Hung Fat. Woo. Yu Cho. Yeung. Chun Yip. Cheung. Bernard Man Yung. 2013-01-23. Elevated Circulating Adipocyte‐Fatty Acid Binding Protein Levels Predict Incident Cardiovascular Events in a Community‐Based Cohort: A 12‐Year Prospective Study. Journal of the American Heart Association. en. 2. 1. e004176. 10.1161/JAHA.112.004176. 2047-9980. 3603238. 23525430.
  10. Lee. Chi-Ho. Lui. David T. W.. Lam. Karen S. L.. 2021. Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality. Frontiers in Immunology. 12. 589206. 10.3389/fimmu.2021.589206. 1664-3224. 8017191. 33815359. free.
  11. Xu. Aimin. Tso. Annette W.K.. Cheung. Bernard M.Y.. Wang. Yu. Wat. Nelson M.S.. Fong. Carol H.Y.. Yeung. Dennis C.Y.. Janus. Edward D.. Sham. Pak C.. Lam. Karen S.L.. 2007-03-27. Circulating Adipocyte–Fatty Acid Binding Protein Levels Predict the Development of the Metabolic Syndrome. Circulation. 115. 12. 1537–1543. 10.1161/CIRCULATIONAHA.106.647503. 17389279. 9975535.
  12. Harris. Margaret. 2009-05-23. Karen Lam Siu-ling: tackling diabetes in Hong Kong. The Lancet. English. 373. 9677. 1755. 10.1016/S0140-6736(09)60970-3. 0140-6736. 19465220. 30592445.
  13. Web site: Wiseman . Alison . 1994-01-25 . Experts call for diabetes fight to be stepped up . 2022-03-27 . South China Morning Post . 3 . en.
  14. News: 5 July 2008. Honors for outstanding women. 3. South China Morning Post. ProQuest.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Karen Lam (researcher)".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.